ZOMETA® Patient Case Study: Breast Cancer Medical Profile – Initial Diagnosis And Treatment

View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

ZOMETA Patient Case Study: Breast Cancer

ZOMETA® Breast Cancer Patient Case Study - Marta

Marta N.

Aged 57 years
Math teacher
Grandmother of 2

Page

1 2 3

Initial diagnosis and treatment

Marta was initially diagnosed with breast cancer in 2002

— Stage IIa adenocarcinoma in the right breast
— Hormone-receptor positive
— HER2 negative

Marta received a lumpectomy followed by chemotherapy (doxorubicin + cyclophosphamide) and 5 years of tamoxifen

Page

1 2 3

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US flag at the top right corner of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.